Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

February 3, 2023

Purple Biotech signs agreement to acquire Immunorizon

Purple Biotech has signed an agreement to acquire Immunorizon, which develops potential multi-specific T and NK cell engager oncology therapies.

Purple Biotech signs agreement to acquire Immunorizon